On March 9, 2022 Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, reported that management will be presenting at the virtual 32nd Annual Oppenheimer Healthcare Conference and participating in the Targeted Oncology Panel as part of the Conference (Press release, Cyclacel, MAR 9, 2022, View Source [SID1234609807]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference details can be found below:

Panel: Targeted Oncology 2.0 – Moving Beyond TKIs
Date: March 14th, 2022
Time: 10:00am ET
Format: Fireside Chat (Registration Link)

Company Presentation
Date: March 17th, 2022
Time: 12:40pm – 1:10pm ET
Format: Fireside Chat (Registration Link)
A replay will be available following the presentation for 90 days